RealTalk MS Reaches a Milestone :26
Join the RealTalk MS Conversation :48
Living with MS? Your Access to Healthcare is Under Attack …Again! 2:53
Mavenclad Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 11:37
Siponimod Receives FDA Approval for Treating Relapsing-Remitting and Active Secondary Progressive MS 15:01
Celgene Submits Application for FDA Approval of Ozanimod for Treating Relapsing-Remitting MS 16:41
My Interview with Dr. Valerie Block 19:16
Download the Free RealTalk MS App 34:04
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: jonstrum@RealTalkMS.com
Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
26 Patient Groups Support Bill to Stabilize and Strengthen the Affordable Care Act
FDA Approves New Oral Treatment for Multiple Sclerosis
FDA Approves New Oral Drug to Treat Multiple Sclerosis
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 84
Hosted By: Jon Strum
Guest: Dr. Valerie Block
Tags: MS, MultipleSclerosis, MSResearch, ProgressiveMS, Mavenclad, EMDSerono, Siponimod, Novartis, Celgene, RealTalkMS